Autorisation d’accès précoce refusée à la spécialité DUVYZAT (givinostat) dans l'indication « traitement de la dystrophie musculaire de Duchenne (DMD) chez les patients ambulants, âgés de 6 ans et plus, recevant un traitement concomitant par corticostéroïdes. »
See also
HAS opinions and decisions
09/12/2025
eNrFmN9v2jAQx9/5K6K8JyEpLTAFqo21G1KrMQratBdkkgsxC3bqHwH6188ButEpWVdTqxIPYDt3F9/XnzscXm5WmVUA45iSnu27TdsCEtEYk0XPnk6unY592W+ES1Sgo2Vtt+n6gW1FGeK8Z5ez7hwQ4e7325uPoJ4HZvcbVkjnS4jEk3VS4Mz9jHh6i/JyjRUWFMfWCkRK456dS7EbtUIumIqiv6bsJ89RBKF3GDmeXc5ax+OhVxr7D6uSA7tBZFFpFIiWzUgyBkQMkIAFZdtK0/nsLOj43bOulgfMx8CpZBGMkEhHjBY4hrjSUYIyDlpOknV8B6zIQJROKo17y2jFtYyjJdqM4X5YHfR7NTsQG+E0Hb/dPg+6Lb8Z+J1AyxU72qpq7aiX8FRC2p3WRdD1gHixLLYPSDgLXGBCuVBf461aTfMUg7OSPJIZwgycWH1klAIhoJnIEWUCZYZSiPngqRYN+WFw/6xUYszzDG3dJc91twoxpKaBKWKYe5HyDSZMMSxTe/aXfSKzzHth1NMDYQxFXAJsQCURNaC5HutuxIASAZv6jOqxUWwOWsTAX8/sAyXVdWEk5xmOdPmnCCWBi+l4WI+/NyPHB8Rhysyh4xsmMV3z10fSsQQMRZ/vqFpdeVnsz4Ju58I/P9c+cT+U3mpq15VUyQZPwQrzUxg0JAk9lT5KwtWmHgX8NtrdNV00QhnUtF2OJrWUaB+7RGPHwtyR209UGv10NdHV0lcJbHu3+1lpGse93yrQQ7qJOqGUWxv4y8/BHgf/bMiTaBZ02q3OmV6TKVk1bVIhcv7O89brtZsi7nCkNstN2NuWjqPSbu7Pg5H+Yd9P7fFrKPT5vq6+LJ26p/O5DuPUrvnw/KE7r/QhmIQTcrEHuTHcDq9en+B/WmZjYY+eEMecm117iwSmxFQnJed1Fxgn1AyVV3LNFCC+JAmuudKp1WXo7a+T+o3QK6+S+o1fBlUv0g==
dPxHktvuvCk0QD2a
